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status (GA+ AA vs. AA). The heart rate variability was obtained into
spectral analysis variables including low (LF) and high frequencies (HF)
and LF/HF ratio (n= 87). Flow-mediated dilation was performed after
30 days (n= 140). Clinical follow-up (n= 331) was carried over until
two years after STEMI and the primary endpoint consisted of fatal and
non-fatal myocardial infarction, unstable angina with hospitalization
and cardiac sudden death. Results: In ANCOVA analysis adjusted for sex
and age, A-allele carriers showed a decreased ﬂow-mediated dilation
[6.13 (7.61) vs 7.29 (6.70); p = 0.025], an increased sympathetic
activity at ﬁrst 24 h [LF/HF 2.29 (3.73) vs 1.55 (2.40); p = 0.026], and it
persists higher between ﬁrst 24 h and ﬁfth day [DeltaLF/HF −0.07
(3.58) vs −0.83 (2.62); p b 0.001]. In the multivariate Cox regression
independent predictors for the primary endpoint were: A-allele carriers
[Relative Risk (RR) = 1.96; 95% Conﬁdence Interval (95% CI): 1.33–
2.90; p = 0.001), arterial hypertension (RR = 2.67; 95% CI: 1.59–4.51;
p b 0.001), age (RR = 1.03; 95% CI: 1.01–1.05; p = 0.002), glycemia at
ﬁfth day (RR = 1.01; 95% CI: 1.00–1.01; p b 0.001) and simvastatin use
in the acute phase (RR = 0.61; 95% CI: 0.39–0.94; p = 0.024).
Conclusions: The presence of the A allele at nNOS gene rs41279104
sequence is associatedwith an impaired endothelial function, increased
sympathetic tone and a higher incidence of recurrent cardiovascular
events after STEMI.
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Introduction: Increased systemic inﬂammatory activity (SIA) during
acute phase of myocardial infarction (MI) is directly associated with the
incidence of lethal ventricular arrhythmias and sudden cardiac death.
Similarly, the extension of the peri-infarct zone (PIZ), as characterized by
cardiac magnetic resonance imaging (CMRI), is associated with the
presence of substrate for generation of ventricular arrhythmias in
patients who recently manifested MI. In this context, this study aims
to: 1) assess whether there is an association between SIA during the
acute phase of MI and the extension of PIZ; 2) assess whether the
emergence of coronary microvascular obstruction, estimated by both
CMRI and coronary angiography, is one of connecting elements between
the SIA and the PIZ; and 3) whether a relationship exists between the
extent of PIZ and the ventricular remodeling after MI, which may
contribute to the link between PIZ and mortality. Methods: We
prospectively included 98 patients (55 ± 10 years) admitted within
12 h ofMIwith ST-segment elevation. Plasma levels of C-reactive protein
(CRP), interleukin-2 (IL-2) and tumor necrosis factor type α (TNF-α)
were assessed at admission (D1) and at the ﬁfth day post-MI (D5). Thirty
days after MI, CMRI was performed to quantify the PIZ and the mass of
MI. Results: BetweenD1 andD5, the relative increases of CRP (6.0 vs. 5.6-
fold, p = 0.02), IL-2 (3.6 vs. 3.4-fold, p = 0.04) and TNF-α (3.9 vs. 4.6-
fold, p = 0.001)were higher in patientswith PIZ above themedian value
(9.98 g) as comparedwith their counterparts. Plasma CRP, IL-2 and TNF-
α at D5 and their respective change from D1 to D5 (delta) were
positively correlated with the extent of PIZ (PCR-D5 r = 0.69,
p b 0.0001; PCR-delta r = 0.7, p b 0.0001; IL-2-D5, r = 0.5, p b 0.0001;
IL-2-delta, r = 0.6, p b 0.0001, TNF-α-D5, r = 0.5, p b 0.0001; TNF-α-
delta, r = 0.4, p = 0.0001). These correlations remained signiﬁcant after
adjustment for age, gender, MI mass and the respective value of these
inﬂammatory mediators assessed at D1. Conclusion: The raise of the SIA
during the acute phase of MI is directly related to the generation of PIZ.
This association should be considered among the potential adverse
effects of excessive increase of AIS during the acute phase of MI.
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Introduction: Following ST Elevation Myocardial Infarction (STEMI),
the ischemic injury motivates an inﬂammatory response, which is a
determinant for myocardial remodeling and mortality. Statin treatment
has shown to attenuate inﬂammatory response in individuals with
hypercholesterolemia and with unstable angina. It is unknown if anti-
inﬂammatory effect may overwhelm the extensive necrosis area in
STEMI and if it is inﬂuenced by the statin therapy. Methods: We
evaluated 247 patients admitted in the ﬁrst 24 h after STEMI. Blood
samples were taken at admission and at the ﬁfth day after STEMI. In a
subgroup, blood samples were daily taken for seven days to determine
the plasma C-reactive protein (CRP). This subgroup was submitted to
nuclear magnetic resonance imaging (MRI) with late enhancement
technique to determine the size of STEMI area. Results:We found aweak
but signiﬁcant correlation between the CRP variation from admission to
the ﬁfth day after STEMI and the peak CK-MB (r = 0.19; p = 0.005). We
did not ﬁnd correlation between STEMI mass and CRP change in the
subgroup of patients submitted toMRI (n= 40). Patients were classiﬁed
in four groups: thosewhowere using statins prior to and duringMI (SS),
statins prior to but not during MI (SN), no statin prior to but during MI
(NS), and no statin prior to nor during MI (NN). Statin users presented a
trend to lower CRP values as compared with those without this
treatment before the MI (NN: 1.0 (0.4–1.5) vs NS: 1.0 (0.3–2.8) vs SS:
0.5 (0.3–1.0) vs SN: 0.6 (0.4–1.0) mg/dL; p = 0.08). By the ﬁfth day, CRP
was signiﬁcantly higher in the SN (18.1 (16.1–23.2)mg/dL) as compared
with other groups (NN: 10.5 (9.3–13.2) vs NS: 2.9 (1.5–4.5) vs SS: 1.1
(0.8–2.4) mg/dL; p b 0.0001). At admission, CRP in the NN group was
lower than in the SN group (p b 0.0001), but higher than the NS and SS
groups (p b 0.0001). Conclusion: The inﬂammatory response, estimated
by CRP, is little or not inﬂuenced by myocardial infarction extension
inferred by CK–MB peak or MRI. The statin withdrawal during STEMI
provokes a rebound inﬂammatory effect. In contrast, prior use of statin
magniﬁes the attenuation of the inﬂammatory response.
doi:10.1016/j.bbacli.2015.05.015
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Introduction: Perirenal fat (PRF) is associated with cardiovascular
risk factors. Gender differences in the correlations of cardiovascular
disease risk factors and PRF in the Brazilian population are lacking.
Methods: Cross-sectional study with 101 (50.49% men; mean age
56.5 ± 18, range 19–74 years) drawn from the Uberlândia Heart
Study underwent ultrasonography assessment of abdominal adipose.
For the perirenal fat, a 3.5 MHz transducer was measured in the
middle third of the right kidney, with the transducer positioned at
the axillary midline. The exams were always performed by the same
examiner. The PRF thickness was examined in relation to waist
circumference, blood pressure and metabolic risk factors. Results:
The PRF was signiﬁcantly associated with the levels of gamma-GT
(p b 0.05, r = 0.08), fasting plasma glucose (p b 0.05, r = 0.07),
waist circumference (p b 0.05, r = 0.10), and metabolic syndrome
(p b 0.001, r = 0.38) in men, and with the levels of fasting plasma
glucose (p b 0.05, in women. Conclusion: The PRF was correlated
with most cardiovascular risk factors in men and only in glucose at
the women.
doi:10.1016/j.bbacli.2015.05.016
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Introduction: Ectopic visceral fat (VF) and subcutaneous (SCF) fat
are associated with cardiovascular risk factors. Gender differences in
the correlations of cardiovascular disease risk factors and ectopic fat
in the Brazilian population are still lacking. Methods: Cross-sectional
study with 101 volunteers (50.49% men; mean age 56.5 ± 18, range
19–74 years) drawn from the Uberlândia Heart Study (UHS). The
volunteers were examined in relation to physical examination and
laboratory. Results: The mean age of the study sample was 48 W and
52 M years, and 48.5% were women, 40.2% was hypertensive, 39,3%
was obese, 61.8% had abdominal obesity, 32% had hypertriglyc-
eridemia, 33.2% low HDL-C and high LDL-C, 40.2% high total
cholesterol, 33.2% high non-HDL-C, 22.7% mixed dyslipidemia,
20.2% impaired fasting glucose and 41.1% had MetS. Conclusion:
The UHS study reported a high prevalence of MetS and risk factors.
doi:10.1016/j.bbacli.2015.05.017
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Introduction: Ectopic visceral fat (VF) and subcutaneous (SCF) fat are
associated with cardiovascular risk factors. Gender differences in the
correlations of cardiovascular disease risk factors and ectopic fat in the
Brazilian population still lacking. Methods: Cross-sectional study with
101 volunteers (50.49% men; mean age 56.5 ± 18, range 19–74 years)
drawn from the Uberlândia Heart Study underwent ultrasonography
assessment of abdominal visceral adipose tissue with convex transducer
of 3.5 MHz of frequency. The thickness of visceral fat was ultra-
sonographically measured by the distance between the inner face of
the abdominal muscle and the posterior face of abdominal aorta, 1 cm
above the umbilicus. The subcutaneous fat thickness wasmeasuredwith
a 7.5 MHz linear transducer transversely positioned 1 cm above the
umbilical scar. The examswere always performedby the same examiner.
EVF volumes were examined in relation to waist circumference, blood
pressure and metabolic risk factors. Results: The VF was signiﬁcantly
associated with the levels of triglycerides (p b 0.01, r = 0.10), HDL-
cholesterol (p b 0.005, r = 0.15), total cholesterol (p b 0.01, r = 0.10),
waist circumference (p b 0.0001, r = 0.43), systolic blood pressure
(p b 0.001, r = 0.41) and diastolic blood pressure (p b 0.001, r = 0.32)
inwomen, andwith the levels of triglycerides (p b 0.002, r = 0,14), HDL-
cholesterol (p b 0.032, r = 0.07), glucose (p b 0.001, r = 0.15), ALT
(p b 0.008, r = 0.12), gamma-GT (p b 0.001, r = 0.30), waist circumfer-
ence (p b 0.001, r = 0.52), systolic blood pressure (p b 0.001, r = 0.32)
and diastolic blood pressure (p b 0.001, r = 0.26) in men. SCF was
signiﬁcantly associated with the levels of triglycerides (p b 0.01,
r = 0.34), LDL-cholesterol (p b 0.001, r = 0.36), total cholesterol
(p b 0.05, r = 0.36), waist circumference (p b 0.0001, r = 0.62), systolic
and diastolic blood pressure (p b 0.05, r = 0.34) inwomen, andwith the
waist circumference (p b 0.001, r = 0.065) and MetS (p b 0.05,
r = 0.11) in men. Conclusion: The VF and SCF were correlated with
most cardiovascular risk factors in both genders.
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Introduction: A high cost-effectiveness has restricted the use of a
thorough assessment of cardiovascular risk biomarkers to estimate
cardiovascular risk in primary prevention, particularly in low-income
populations. In this context, the development of screening tests has
been pursued as a way to provide feasibility. Our hypothesis is that
the measurement of plasma C-reactive protein (CRP) can be used in
this setting and may help to select individuals in whom a detailed
assessment of risk factors is worthwhile. Methods: Asymptomatic
healthy individuals (n = 320; 19–77 years old) were separated in
groups according to the plasma CRP as b0.1 mg/dL (0.00–0.96) or
≥0.1 mg/dL (0.10–3.74). A careful clinical examination was followed
by plasma biochemical analyses and carotid intima–media thickness
(cIMT) measurement. The presence of cIMT ≥0.90 mm was consid-
ered as the endpoint in the multivariable binary logistic regression
models used to evaluate the association between cIMT across CRP
and levels of metabolic or anthropometrics parameters. ROC curves
were used to compare the predictive value of the atherosclerotic
cardiovascular disease (ASCVD) risk algorithm in the two groups.
Results: The following risk factors were associated with increased
cIMT in high CRP group: age (odds ratio: 1.10; 95% conﬁdence
interval (CI): 1.05–1.15; p = 0.0001), male gender (odds ratio: 5.08;
95% CI: 1.9–13.7; p = 0.004), systolic blood pressure (odds ratio:
1.04; 95% CI: 1.01–1.07; p = 0.013), Non-high-density lipoprotein
cholesterol (odds ratio: 1.02; 95% CI: 1.00–1.04; p = 0.038), Low-
density lipoprotein cholesterol (odds ratio: 1.02; 95% CI: 1.00–1.04;
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